HEADER PROTEIN BINDING 30-OCT-23 8WY7 TITLE CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX TITLE 2 WITH THE INHIBITOR 22 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: PROTEIN HUNK1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BRD4(1), BROMODOMAIN, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR H.XU,X.ZHAO,H.SHEN,Y.XU,X.WU REVDAT 2 07-FEB-24 8WY7 1 JRNL REVDAT 1 24-JAN-24 8WY7 0 JRNL AUTH W.JIANG,Q.HOU,H.XU,K.YANG,X.WANG,K.ZHANG,Y.ZENG,W.LI,B.WANG, JRNL AUTH 2 G.LUO,X.ZHAO,H.SHEN,Y.XU,X.WU JRNL TITL DISCOVERY OF NOVEL PHENOXYARYL PYRIDONES AS BROMODOMAIN AND JRNL TITL 2 EXTRA-TERMINAL DOMAIN (BET) INHIBITORS WITH HIGH SELECTIVITY JRNL TITL 3 FOR THE SECOND BROMODOMAIN (BD2) TO POTENTIALLY TREAT ACUTE JRNL TITL 4 MYELOID LEUKEMIA. JRNL REF J.MED.CHEM. V. 67 1513 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38175809 JRNL DOI 10.1021/ACS.JMEDCHEM.3C02104 REMARK 2 REMARK 2 RESOLUTION. 2.83 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0189 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.83 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 121.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 17230 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 884 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.83 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1314 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2430 REMARK 3 BIN FREE R VALUE SET COUNT : 65 REMARK 3 BIN FREE R VALUE : 0.2360 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2731 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 120 REMARK 3 SOLVENT ATOMS : 4 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 88.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.64000 REMARK 3 B22 (A**2) : -0.64000 REMARK 3 B33 (A**2) : 2.08000 REMARK 3 B12 (A**2) : -0.32000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.421 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.335 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.241 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.414 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2932 ; 0.016 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 2698 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3994 ; 1.870 ; 2.001 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6281 ; 1.124 ; 3.013 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 320 ; 6.456 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 141 ;39.899 ;25.603 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 513 ;16.944 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;16.392 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 421 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3129 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 576 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1298 ; 6.915 ; 8.692 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1299 ; 6.912 ; 8.694 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1612 ; 9.597 ;13.035 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1613 ; 9.595 ;13.037 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1634 ; 7.149 ; 9.181 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1635 ; 7.146 ; 9.182 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2383 ;10.361 ;13.534 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3412 ;12.660 ;96.694 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3413 ;12.659 ;96.706 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8WY7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 02-NOV-23. REMARK 100 THE DEPOSITION ID IS D_1300042260. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUL-23 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL10U2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18153 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.830 REMARK 200 RESOLUTION RANGE LOW (A) : 134.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 200 DATA REDUNDANCY : 17.50 REMARK 200 R MERGE (I) : 0.20800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.83 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.98 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 20.70 REMARK 200 R MERGE FOR SHELL (I) : 0.94900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MERLOT REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.0 M SODIUM FORMATE, 0.1 M TRIS PH REMARK 280 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.76633 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 89.53267 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 67.14950 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 111.91583 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 22.38317 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 44.76633 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 89.53267 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 111.91583 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 67.14950 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 22.38317 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -22.38317 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 28 REMARK 465 LYS A 29 REMARK 465 LYS A 30 REMARK 465 GLY A 31 REMARK 465 HIS A 32 REMARK 465 HIS A 33 REMARK 465 HIS A 34 REMARK 465 HIS A 35 REMARK 465 HIS A 36 REMARK 465 HIS A 37 REMARK 465 LEU A 38 REMARK 465 VAL A 39 REMARK 465 PRO A 40 REMARK 465 ARG A 41 REMARK 465 GLY A 42 REMARK 465 SER A 43 REMARK 465 ASN A 44 REMARK 465 PRO A 45 REMARK 465 PRO A 46 REMARK 465 PRO A 47 REMARK 465 PRO A 48 REMARK 465 GLU A 49 REMARK 465 THR A 50 REMARK 465 SER A 51 REMARK 465 ASN A 52 REMARK 465 PRO A 53 REMARK 465 ASN A 54 REMARK 465 LYS A 55 REMARK 465 PRO A 56 REMARK 465 LYS A 57 REMARK 465 ARG A 58 REMARK 465 GLN A 59 REMARK 465 GLU A 167 REMARK 465 GLU A 168 REMARK 465 MET B 28 REMARK 465 LYS B 29 REMARK 465 LYS B 30 REMARK 465 GLY B 31 REMARK 465 HIS B 32 REMARK 465 HIS B 33 REMARK 465 HIS B 34 REMARK 465 HIS B 35 REMARK 465 HIS B 36 REMARK 465 HIS B 37 REMARK 465 LEU B 38 REMARK 465 VAL B 39 REMARK 465 PRO B 40 REMARK 465 ARG B 41 REMARK 465 GLY B 42 REMARK 465 SER B 43 REMARK 465 ASN B 44 REMARK 465 PRO B 45 REMARK 465 PRO B 46 REMARK 465 PRO B 47 REMARK 465 PRO B 48 REMARK 465 GLU B 49 REMARK 465 THR B 50 REMARK 465 SER B 51 REMARK 465 ASN B 52 REMARK 465 PRO B 53 REMARK 465 ASN B 54 REMARK 465 LYS B 55 REMARK 465 PRO B 56 REMARK 465 LYS B 57 REMARK 465 ARG B 58 REMARK 465 GLN B 59 REMARK 465 THR B 60 REMARK 465 GLU B 168 REMARK 465 MET C 28 REMARK 465 LYS C 29 REMARK 465 LYS C 30 REMARK 465 GLY C 31 REMARK 465 HIS C 32 REMARK 465 HIS C 33 REMARK 465 HIS C 34 REMARK 465 HIS C 35 REMARK 465 HIS C 36 REMARK 465 HIS C 37 REMARK 465 LEU C 38 REMARK 465 VAL C 39 REMARK 465 PRO C 40 REMARK 465 ARG C 41 REMARK 465 GLY C 42 REMARK 465 SER C 43 REMARK 465 ASN C 44 REMARK 465 PRO C 45 REMARK 465 PRO C 46 REMARK 465 PRO C 47 REMARK 465 PRO C 48 REMARK 465 GLU C 49 REMARK 465 THR C 50 REMARK 465 SER C 51 REMARK 465 ASN C 52 REMARK 465 PRO C 53 REMARK 465 ASN C 54 REMARK 465 LYS C 55 REMARK 465 PRO C 56 REMARK 465 LYS C 57 REMARK 465 GLU C 167 REMARK 465 GLU C 168 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 69 -61.35 -105.19 REMARK 500 ASN A 93 63.97 63.07 REMARK 500 ASN A 117 57.22 -109.17 REMARK 500 PRO A 165 158.53 -46.23 REMARK 500 PRO B 165 -179.41 -68.17 REMARK 500 GLN C 59 57.17 -103.01 REMARK 500 ASN C 116 31.08 -140.70 REMARK 500 PRO C 165 174.40 -54.95 REMARK 500 REMARK 500 REMARK: NULL DBREF 8WY7 A 44 168 UNP O60885 BRD4_HUMAN 44 168 DBREF 8WY7 B 44 168 UNP O60885 BRD4_HUMAN 44 168 DBREF 8WY7 C 44 168 UNP O60885 BRD4_HUMAN 44 168 SEQADV 8WY7 MET A 28 UNP O60885 INITIATING METHIONINE SEQADV 8WY7 LYS A 29 UNP O60885 EXPRESSION TAG SEQADV 8WY7 LYS A 30 UNP O60885 EXPRESSION TAG SEQADV 8WY7 GLY A 31 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS A 32 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS A 33 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS A 34 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS A 35 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS A 36 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS A 37 UNP O60885 EXPRESSION TAG SEQADV 8WY7 LEU A 38 UNP O60885 EXPRESSION TAG SEQADV 8WY7 VAL A 39 UNP O60885 EXPRESSION TAG SEQADV 8WY7 PRO A 40 UNP O60885 EXPRESSION TAG SEQADV 8WY7 ARG A 41 UNP O60885 EXPRESSION TAG SEQADV 8WY7 GLY A 42 UNP O60885 EXPRESSION TAG SEQADV 8WY7 SER A 43 UNP O60885 EXPRESSION TAG SEQADV 8WY7 MET B 28 UNP O60885 INITIATING METHIONINE SEQADV 8WY7 LYS B 29 UNP O60885 EXPRESSION TAG SEQADV 8WY7 LYS B 30 UNP O60885 EXPRESSION TAG SEQADV 8WY7 GLY B 31 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS B 32 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS B 33 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS B 34 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS B 35 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS B 36 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS B 37 UNP O60885 EXPRESSION TAG SEQADV 8WY7 LEU B 38 UNP O60885 EXPRESSION TAG SEQADV 8WY7 VAL B 39 UNP O60885 EXPRESSION TAG SEQADV 8WY7 PRO B 40 UNP O60885 EXPRESSION TAG SEQADV 8WY7 ARG B 41 UNP O60885 EXPRESSION TAG SEQADV 8WY7 GLY B 42 UNP O60885 EXPRESSION TAG SEQADV 8WY7 SER B 43 UNP O60885 EXPRESSION TAG SEQADV 8WY7 MET C 28 UNP O60885 INITIATING METHIONINE SEQADV 8WY7 LYS C 29 UNP O60885 EXPRESSION TAG SEQADV 8WY7 LYS C 30 UNP O60885 EXPRESSION TAG SEQADV 8WY7 GLY C 31 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS C 32 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS C 33 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS C 34 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS C 35 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS C 36 UNP O60885 EXPRESSION TAG SEQADV 8WY7 HIS C 37 UNP O60885 EXPRESSION TAG SEQADV 8WY7 LEU C 38 UNP O60885 EXPRESSION TAG SEQADV 8WY7 VAL C 39 UNP O60885 EXPRESSION TAG SEQADV 8WY7 PRO C 40 UNP O60885 EXPRESSION TAG SEQADV 8WY7 ARG C 41 UNP O60885 EXPRESSION TAG SEQADV 8WY7 GLY C 42 UNP O60885 EXPRESSION TAG SEQADV 8WY7 SER C 43 UNP O60885 EXPRESSION TAG SEQRES 1 A 141 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS LEU VAL PRO SEQRES 2 A 141 ARG GLY SER ASN PRO PRO PRO PRO GLU THR SER ASN PRO SEQRES 3 A 141 ASN LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU SEQRES 4 A 141 LEU ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE SEQRES 5 A 141 ALA TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 6 A 141 ASN LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET SEQRES 7 A 141 ASP MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR SEQRES 8 A 141 TYR TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR SEQRES 9 A 141 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP SEQRES 10 A 141 ASP ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE SEQRES 11 A 141 LEU GLN LYS ILE ASN GLU LEU PRO THR GLU GLU SEQRES 1 B 141 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS LEU VAL PRO SEQRES 2 B 141 ARG GLY SER ASN PRO PRO PRO PRO GLU THR SER ASN PRO SEQRES 3 B 141 ASN LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU SEQRES 4 B 141 LEU ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE SEQRES 5 B 141 ALA TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 6 B 141 ASN LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET SEQRES 7 B 141 ASP MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR SEQRES 8 B 141 TYR TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR SEQRES 9 B 141 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP SEQRES 10 B 141 ASP ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE SEQRES 11 B 141 LEU GLN LYS ILE ASN GLU LEU PRO THR GLU GLU SEQRES 1 C 141 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS LEU VAL PRO SEQRES 2 C 141 ARG GLY SER ASN PRO PRO PRO PRO GLU THR SER ASN PRO SEQRES 3 C 141 ASN LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU SEQRES 4 C 141 LEU ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE SEQRES 5 C 141 ALA TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 6 C 141 ASN LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET SEQRES 7 C 141 ASP MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR SEQRES 8 C 141 TYR TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR SEQRES 9 C 141 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP SEQRES 10 C 141 ASP ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE SEQRES 11 C 141 LEU GLN LYS ILE ASN GLU LEU PRO THR GLU GLU HET XHN A 201 40 HET XHN B 201 40 HET XHN C 201 40 HETNAM XHN 2-[[5-[2-(4-FLUORANYL-2,6-DIMETHYL-PHENOXY)-5-(2- HETNAM 2 XHN OXIDANYLPROPAN-2-YL)PHENYL]-1-METHYL-2-OXIDANYLIDENE- HETNAM 3 XHN PYRIDIN-4-YL]AMINO]-~{N}-(4-OXIDANYLCYCLOHEXYL) HETNAM 4 XHN ETHANAMIDE FORMUL 4 XHN 3(C31 H38 F N3 O5) FORMUL 7 HOH *4(H2 O) HELIX 1 AA1 ASN A 61 VAL A 69 1 9 HELIX 2 AA2 VAL A 69 HIS A 77 1 9 HELIX 3 AA3 ALA A 80 GLN A 84 5 5 HELIX 4 AA4 ASP A 88 ASN A 93 1 6 HELIX 5 AA5 ASP A 96 ILE A 101 1 6 HELIX 6 AA6 ASP A 106 ASN A 116 1 11 HELIX 7 AA7 ASN A 121 ASN A 140 1 20 HELIX 8 AA8 ASP A 144 ASN A 162 1 19 HELIX 9 AA9 GLN B 62 VAL B 69 1 8 HELIX 10 AB1 VAL B 69 HIS B 77 1 9 HELIX 11 AB2 ALA B 80 GLN B 84 5 5 HELIX 12 AB3 ASP B 96 ILE B 101 1 6 HELIX 13 AB4 ASP B 106 ASN B 116 1 11 HELIX 14 AB5 ASN B 121 ASN B 140 1 20 HELIX 15 AB6 ASP B 144 GLU B 163 1 20 HELIX 16 AB7 ASN C 61 VAL C 69 1 9 HELIX 17 AB8 VAL C 69 HIS C 77 1 9 HELIX 18 AB9 ALA C 80 GLN C 84 5 5 HELIX 19 AC1 ASP C 88 ASN C 93 1 6 HELIX 20 AC2 ASP C 96 ILE C 101 1 6 HELIX 21 AC3 ASP C 106 ASN C 116 1 11 HELIX 22 AC4 ASN C 121 ASN C 140 1 20 HELIX 23 AC5 ASP C 144 GLU C 163 1 20 CRYST1 140.150 140.150 134.299 90.00 90.00 120.00 P 61 2 2 36 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007135 0.004120 0.000000 0.00000 SCALE2 0.000000 0.008239 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007446 0.00000